Condition
Clostridium Difficile Infection Recurrence clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Clostridium Difficile Infection Recurrence clinical trials that are recruiting, at sites in 25 countries (most in United States (3), Australia (1), Belgium (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 25Countries
Newest Clostridium Difficile Infection Recurrence clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ibezapolstat for recurrent C. difficile infection in adults | Phase 2 | Sacramento, California and 18 other locations | Recruiting | Apr 7, 2026 |
| Long-term effectiveness and safety of fecal microbiota transplantation | — | Shanghai, Shanghai Municipality | Recruiting | Dec 3, 2025 |
| VE303 for preventing recurrent Clostridioides difficile infections | Phase 3 | Huntsville, Alabama and 214 other locations | Recruiting | Feb 1, 2024 |
| Fecal microbiota transplantation for treating recurrent C. difficile infections | — | Worcester, Massachusetts | Recruiting | Jun 19, 2018 |
All recruiting trials (4)
-
Ibezapolstat for recurrent C. difficile infection in adults
A small, single-arm study tests ibezapolstat to see if it can prevent further C. difficile flares in adults who have had three or more episodes in the past year.
-
Long-term effectiveness and safety of fecal microbiota transplantation
This project will follow about 4,000 people who have had fecal microbiota transplantation to see if it helps keep them in remission and is safe over 3 months, 1 year, and 5 years for conditions like recurrent C. difficile, IBD, IBS, and chronic constipation.
-
VE303 for preventing recurrent Clostridioides difficile infections
This study is testing a new treatment called VE303 to see if it can help prevent Clostridioides difficile infections from coming back in people who are at high risk.
-
Fecal microbiota transplantation for treating recurrent C. difficile infections
This study is testing whether a stool transplant from a healthy donor can help people with repeated C. difficile infections feel better compared to regular antibiotic treatments.
Related topics
Quick answers
How many Clostridium Difficile Infection Recurrence clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 25 countries. The most sites are in United States (3 trials), Australia (1 trial), Belgium (1 trial), Brazil (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.